Diabetes deaths in the United States continue to surge well above pre-pandemic levels with over 100,000 Americans dying from diabetes in 2021. Increasing deaths from diabetes is a clear call to action for new solutions. Historically, diabetes has been treated as a chronic disease, managed with a lifetime of medications. However, a new line of thinking about diabetes remission permeates the literature.
Precision’s Cynthia Miller reviews two new proposed pathways to diabetes management, the impact on healthcare stakeholders and the feasibility of implementation.
